Genetic signaling and redox homeostasis are required for proper growth of blood vessels. Here, we report a novel function of peroxiredoxin1 (Prdx1) in vascular development in zebrafish. Knockdown of prdx1 impairs the growth of intersegmental vessel and caudal vein plexus (CVP), and reduces the expression of vascular markers, thus suggesting a role for prdx1 in vasculature and indicating that the antioxidant function of prdx1 is important. We found that H 2 O 2 -treated embryos also have CVP defects and observed synergistic effects when prdx1 knockdown was combined with H 2 O 2 treatment. Moreover, N-acetyl-cysteine treatment rescues the vascular defects in prdx1 morphants. These results suggest that oxidative stress disturbs vascularization. Furthermore, we show that the regulation of prdx1 is mediated by Notch and BMP signals.
The formation of blood vessels is essential for embryonic survival and must be precisely patterned and controlled. During vasculogenesis, the arteries and veins are formed from angioblast progenitors [1] . Following the establishment of these vessels, additional trunk vessels develop from existing vessels called angiogenesis [2, 3] . The zebrafish is an ideal organism to explore vascular development due to the accessibility and transparency of the embryo and the genetic tools available. Moreover, the cellular and molecular mechanisms underlying vascular development have been conserved throughout vertebrate evolution. Zebrafish have been successfully used to explore the molecular mechanisms of blood vessel formation, including initial angioblast specification, artery and vein identity, vessel angiogenesis, and vasculature patterning and morphogenesis [4] [5] [6] [7] [8] [9] .
Arteries and veins are formed from angioblast progenitors and are specified mainly via VEGF-Notch signaling pathways [10] . After the arteries and veins have formed, angioblasts undergo further proliferation and migration to form a patterned network of smaller vessels. The early, rapid stereotypic intersegmental vessel (ISV) growth in zebrafish trunks makes it ideal for investigating angiogenesis [7] . Several molecules have been identified as mediating the timing and direction of sprouting in these vessels. As the vessels migrate, the leading tip cell plays an active role in sensing the environment for guidance cues, while nonmigratory stalk cells behind tip cells lose filopodia and form a Abbreviations CVP, caudal vein plexus; ISV, intersegmental vessel; NAC, N-acetyl-cysteine; Prdx1, peroxiredoxin1.
lumen [11] [12] [13] [14] [15] . The molecular signals involved in specifying a tip versus a stalk cell are not fully understood. Notch signaling and VEGFC/VEGFR3 signals are involved in determining tip-stalk cell fate [13, 16] . In addition to sprouting dorsally to form ISV, a recent study showed that endothelial cells also sprout ventrally from axial veins to form a honeycomb-like network called caudal vein plexus (CVP) via distinct BMP signaling pathways [17] . Although many molecules have been shown to play a role in vascular development, knowledge is incomplete regarding regulators/ mediators and related signalings in angiogenesis during embryogenesis. In addition, information about antioxidant genes involved in vascular development is limited.
Increase of reactive oxygen species (ROS) or decreased function of antioxidant genes will lead to oxidative stress. ROS, including the superoxide anion, hydrogen peroxide (H 2 O 2 ), and the hydroxyl radical, can cause various kinds of biological damage and have been implicated in the pathogenesis of vascular disease, including atherosclerosis and hypertension [18] [19] [20] . Optimal concentrations of ROS serve as intracellular signals, known as 'Redox signaling', mediate normal physiological vasculature processes. ROS signals are involved in many cellular functions including proliferation, migration, and differentiation [21] . However, the increase of ROS may overwhelm cellular antioxidant defenses under various stresses resulting in oxidative damage in cells. Aerobic organisms have enzymatic antioxidants such as superoxide dismutases (sod), catalases (cat), glutathione peroxidases (gpx), glutaredoxins (grx), and peroxiredoxins (prdx), which eliminate ROS and maintain the cellular redox state. Peroxiredoxins are a family of antioxidant proteins ubiquitously conserved in a wide variety of organisms ranging from bacteria to humans. In the zebrafish (Danio rerio), six peroxiredoxins Prx1-6 have been identified. Of these, Prdx1 is highly abundant cytosolic thioredoxin-dependent peroxidase and is more efficient at removing hydrogen peroxide and organic hydroperoxides. Peroxiredoxin 1 has been reported to protect genomic stability and prevent mutations [22] . In addition, prdx1 helps regulate cell proliferation, growth control, differentiation, immune responses, tumorigenesis, and apoptosis [23, 24] . In cell culture-based studies, Prdx1 has been shown to promote endothelial cell proliferation mediated by TLR4-dependent activation of HIF1a [24] .
Although many studies have shown a connection between oxidative stress and vascular diseases and angiogenesis [25] , most such studies focused on adult animals under pathological conditions and provide only very limited information about oxidative stress and vascular development during embryogenesis.
Recent zebrafish studies have shown that glutaredoxin regulates redox signaling to control vascular development by modifying sirtuin1 [26] and antioxidant enzyme Ubiad1 regulates endothelial NO signals to protect cardiovascular development [27] . An understanding of the molecular mechanism by which antioxidant genes control vascular development is limited, although a recent paper showed Prdx2 regulates PDGFR and VEGF activity and contributes to angiogenesis in mice [28, 29] . Here, we describe a novel function of prdx1 that plays critical roles in vascular growth during zebrafish development.
Materials and methods

Zebrafish strains and husbandry
Zebrafish (Danio rerio) wild-type AB strain and transgenic lines: Tg(kdrl:eGFP) la116 , Tg(fli1a:egfp)
y1
, Tg(kdrl: mCherry) ci5 , and Tg(fli1a:negfp) y7 [5, [30] [31] [32] were obtained from the Taiwan Zebrafish Core Facility and were raised and maintained at the 28.5°C environment [33] . All experimental protocols were approved by and conducted in accordance with the National Sun Yat-sen University Animal Care Committee (approval reference #10231). For overexpression and rescue experiments, capped and polyadenylated mRNA of prdx1 was synthesized by SP6 RNA polymerase in vitro using the mMESSAGE mMASCHINE kit (Ambion, Austin, TX, USA).
Embryo raising and chemical treatments
RNA extraction and cDNA preparation
Total RNA was prepared using the RNeasy kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. cDNA was generated from 1 ng of total RNA using a mix of oligo-dT primer (Invitrogen, Carlsbad, CA, USA) and the RT-reverse transcriptase (Roche, Branford, CT, USA) according to manufacturer's instructions.
Semiquantitative PCR amplification and Quantitative PCR (qPCR) analysis
Semiquantitative PCR amplifications were carried out using Taq DNA polymerase (New England Biolabs, Ipswich, MA, USA), dNTP (10 mM; Roche), forward and reverse primers synthesized from IDT Inc. (Coralville, IA, USA), and 1 lL of cDNA template. PCR products were separated and band density differentiated by electrophoresis in 1% agarose. Quantitative PCR (qPCR) was performed using the LightCycle 96 real-time PCR detection system (Roche) and SYBR Green I Master (Roche). Relative cDNA amounts were calculated using the LC96 program and normalized to the expression of b-actin or GAPDH based on the DDC t method. All reactions were performed as biological triplicates. Primer sequences were listed in the Table S1 .
Whole-mount in situ hybridization and cryosection
Whole-mount in situ hybridization was performed with the high-resolution protocol as described previously [36] . For in situ probes generation, ephrinb2, mrc1, flt4, and stabilin are described previously [14, 37] and prdx1 antisense in situ probes were made by PCR amplifying about 0.5 kb using primers listed in Table S1 and in vitro transcription using T7 Polymerase (Roche) with DIG-labeled RNA labeling kit (Roche). For the hybridization procedure, briefly, embryos will be fixed using 4% paraformaldehyde (Sigma) and stored at À20°C in methanol. After rehydration, permeabilization with proteinase K (Roche), probes are hybridized at 65°C overnight, then washed, blocked, and incubated with alkaline-phosphatase-conjugated anti-Dig antibody. The embryos were then developed in 5-Bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium (Roche) solution at room temperature. After the reaction, embryos were embedded in 3% methylcellulose and photographed on Lumar V12 (Carl Zeiss, Jena, Germany). For cryosectioning, embryos were fixed with tissue freezing medium Tek OCT Compound and sectioned at 10 lM using a Leica CM3050S cryostat and photographed on IX71 inverted microscope (Olympus, Tokyo, Japan).
Image acquisition and processing
Embryos were mounted in 3% methylcellulose (Sigma) or 1.5% low melt agarose (Invitrogen) and image captured with a color digital AxioCam HRc camera (Carl Zeiss) or SPOT RT3 camera (Diagnostic Inc., Sterling heights, MI, USA). For the confocal images, embryos were embedded in 1.5% low melting point agarose with 5% tricaine (Invitrogen) and images were collected on a Zeiss LSM700 or Nikon Eclipse 90i C1 confocal microscopes, and processed in IMAGEJ software (NIH, Bethesda, MD, USA). Additional methods in morpholino efficiency, acridine orange staining, TUNEL assay and Western blot analysis are described in supporting information Doc. S1.
Results
Prdx1 is conserved from yeast to vertebrates and expressed in developing vessels
We are interested in the genetic control of vascular development. Redox homeostasis is important for the proper growth of blood vessels [25] . Prdx1 encodes a cytosolic thioredoxin-dependent peroxidase mainly responsible for the removal of hydrogen peroxide and organic hydroperoxides and has been shown to play an important role in many biological functions. Thus, we investigated the role of prdx1 in vasculature using zebrafish as a model organism. Comparison of zebrafish Prdx1 (Danio rerio, accession NP_001013489.1), with human (Homo sapiens, NP_859048.1), mouse (Mus musculus, NP_035164), chicken (Gallus gallus, NP_001258861.1), and yeast Tsa1 protein (Saccharomyces cerevisiae, NP_013684.1) showed high amino acid identity among vertebrates (≥ 80%); even compared to yeast, there was~60% identity, indicating that zebrafish peroxiredoxin is highly evolutionary conserved across multiple species (Fig. S1A,C) . Phylogenetic analysis of Prdx1 orthologs in different species using CLUSTALW2 program (EMBL-EBI, Hinxton, Cambridge, UK) with the neighbor-joining method is consistent with the sequence alignment that reveals Prdx1 is highly conserved from yeast to mammals. Prdx1 contains four highly conserved domains, including YF motif, GGLG motif, and two conserved enzymatic regions: peroxidatic (C P ) motif and resolving (C R ) motif containing active cysteine residues (Fig. S1A ) that are critical for peroxide degradation activity.
To determine the vascular function of prdx1, we first examined the expression pattern of prdx1 during zebrafish development. prdx1 expression is observed at the 18S stage in the telencephalon and midbrain of head region, and in the lateral plate mesoderm (lpm), which is consistent with the timing of vascular development. At 24 hpf, prdx1 is expressed in the telencephalon and midbrain, in axial vessels, and the CVP of the trunk (Fig. 1A ,B,B 0 ). Cross-sections of embryos show that prdx1 is expressed in the dorsal aorta (da), posterior cardinal vein (pcv), and CVP ( Fig. 1B″ ). At 30 hpf, prdx1 expression continues in the head, vessels (v), ISVs, and the CVP of the trunk. At 36 hpf, prdx1 is expressed in the head and neuron cells on the dermis, but with less expression in vessels. Thus, prdx1 is expressed in developing vessels and switches to neural expression after 36 hpf (Fig. 1D,D 0 ), suggesting a potential role of Prdx1 in vascular development during embryogenesis.
Loss of prdx1 causes vascular defects
Knockdown of prdx1 in transgenic Tg (flk:eGFP) using prdx1 atg MO showed strongly reduced sprouting from the caudal vein compared to wild-type controls ( Fig. 2A ,B,I) with a~10-fold decrease in sprouts observed (n = 42 wt and n = 35 prdx1 MO). At 32 hpf, we observed a slight pericardial edema in prdx1 atg morphants compared to wild-type controls (Fig. 2C,D) . At 32 hpf, in uninjected control embryos, ISVs reached the DLAV at the dorsal aspect of the embryo and the CVP formed loop structures at the tail (Fig. 2E) . At the same stage, ISVs were stalled at midsomite in prdx1 atg morphants with~90% of ISVs incomplete as compared to wt controls (n = 40 in prdx1 MO and n = 40 in wt) (Fig. 2F,J) .
To evaluate whether the abnormal vascular defects was loss-of-prdx1 specific, we used an independent MO (prdx1 i2e3 MO) that targeted the intron2 and exon3 boundary to interrupt the splicing process to reduce prdx1 splicing. Our results showed nearly identical vascular phenotypes as prdx1 atg morphants, including (a) less or no angiogenic sprouting from the caudal vein at 26 hpf (n = 10 in wt and n = 16 in prdx1 MO) ( Fig. S2D-F) . In addition, we tested the efficiency of prdx i2e3 MO knockdown. Injection of 8 ng of prdx1 i2e3 MO disrupted the normal splicing of prdx1 (531 bp) resulting in extra intron 2 (253 bp) in the misspliced transcripts (784 bp) as determined by RT-PCR (Fig. S2G,H) . To confirm the efficacy of MO knockdown, we performed a western blot analysis and showed the reduction of Prdx1 protein levels in both ATG and splicing MOs injected embryos (Fig. S2I) . These data are consistent with the efficacy and specificity of prdx1 knockdown by MO. Moreover, injection of 10 ng control MO or prdx2 MO did not cause vascular defects in the ISVs or CVP (Fig. S3A-J) indicating the phenotypic specificity of MO knockdown of prdx1. We also assessed the gross developmental process in prdx1 morphants and showed that expression of cmlc2 (heart marker), myoD (somite marker), sox3, and shh (neural markers) are unaffected ( Fig. S4A-H) . We also showed that loss of prdx1 did not cause developmental delay by measuring the heart rate at 24-25 hpf (Fig. S4I) . Loss of prdx1 resulted in vascular growth defects suggesting impairment of endothelial cellular migration, proliferation, or increased cell death. To test these hypotheses, we first performed Acridine Orange staining and TUNEL assay to determine whether there was more cell death in the prdx1 morphant. Loss of prdx1 indicated an increase of apoptotic cells at the somites and/or epidermis in the trunk compared to wild-type embryos, but not in vessels (Fig. S5A ,B,D, E). In addition, coinjection of prdx1 MO with p53 MO showed a reduction of apoptotic cells but vascular defects in the ISVs and CVP were still present (Fig. S5C) . These data suggest the vascular defect is not due to the endothelial cell death. To test if loss of prdx1 would decrease cell proliferation or migration, we examined the ISV growth and the numbers of endothelial cells per ISV in the Tg (kdrl:mCherry ci5 ; fli1a:negfp y7 ) embryos, where GFP was expressed in the nucleus of endothelial cells and mCherry was expressed in endothelial ISV cells. Loss of prdx1 slowed or stopped growth at the middle of somites, and significantly reduced ISV cells compared to uninjected wild-type controls (Fig. 2G,H ,K, n = 16 in prdx1 morphants and n = 18 in wt controls, P < 0.0001). These data suggest that prdx1 is required for ISV cell growth to contribute to the vasculature, likely by regulation of the proliferation and/or migration of the endothelial cells.
Knockdown of prdx1 results in edema, circulation defect, and absent parachordal vessels
We observed a slight edema at 32 hpf in prdx1 MO. At 48-72 hpf, we found that a loss of prdx1 caused increasing pericardial edema. Embryos showed~70% pericardial edema at 72 hpf higher than wt controls 8% (n = 20 in wt and n = 20 in prdx1 morphants) (Fig. S6A,B,G) . As edema and loss of circulation are common secondary effects in vessels malformation, we examined the blood flow in wild-type and prdx1 i2e3 morphants using transgenic Tg (fli:eGFP y1
; gata1: dsRed) embryos with GFP-labeled endothelial cells and dsRed-labeled blood cells. Loss of prdx1 showed a growth defect of the ISVs and resulted in slow to no circulation at 48-72 hpf compared to wild-type fish (Fig. S6C,D) . Fewer than 10% of prdx1 morphants had circulation in the axial vessels and/or ISV circulation (n = 11 in wt and n = 10 in prdx1 morphants) (Fig. S6H) . At the 48 hpf stage, we observe an absence of parachordal chain sprouting and formation, which eventually form the lymphatic network and the thoracic duct (Fig. S5E,F) . These data correlate with the vasculature defects in the prdx1-deficient fish.
Knockdown of prdx1 reduces the expression of vascular markers
The vascular defects in ISV growth and CVP formation suggest that prdx1 is critical to vascular development and likely modulates vascular identity. Thus, we examined the expression of several vascular markers, stabilin, flt4, mrc1, and ephrinb2 at 24 hpf by wholemount in situ hybridization. We found that expression of the pan-vascular markers stabilin, venous/ISV-specific marker flt4, venous marker mrc1, and arterial marker ephrinb2 were decreased in the trunk and CVP of prdx1 morphants (dash arrow in Fig. 3B,D , F,H) compared to the wild-type. The decreased level of vascular marker expression was quantified by qPCR and identified a 55-70% decreased expression in prdx1 morphants (Fig. 3I) . These results suggest that prdx1 modulated the expression of several vascular genes to promote vessel formation. Interestingly, we found loss of endothelial cell markers likely switched to blood lineage because the decreased expression of vascular markers coincidently increased the expression of blood markers gata1, globin, and lmo2 (see Fig. 8 in 'Discussion').
Prdx1 peroxidase activity is important for vascular patterning
Prdx1 encodes a peroxiredoxin mainly responsible for the removal of hydrogen peroxide and organic hydroperoxides. Loss of prdx1 function will elevate oxidative stress, as shown in many studies. Our results here showed knockdown of prdx1 causes vascular defects therefore suggesting oxidative stress is increased in prdx1 morphants and attributed to vascular defects. To test this hypothesis, we first tested if oxidative stress disrupted vascular patterning. We found that oxidative stress generation by exogenous 2 mM H 2 O 2 treatment reduced angiogenic sprouting from the caudal vein compared to wild-type control at 26 hpf (Fig. 4A-C) . At 30 hpf, the loop structures formed from sprouting vessels fusion in CVP (refer to CVP structure) were reduced in H 2 O 2 -treated embryos compared to the wildtype control (Fig. 4D-F) . We confirmed this defect in CVP is dose-dependent (data not shown). However, no obvious defects in ISV growth were found in the H 2 O 2 -treated embryos (arrowheads in Fig. 4D ,E,G,H), but DLAVs have not completely connected (hollow arrowheads in E). These data suggest that oxidative stress induced by H 2 O 2 indeed affects CVP patterning but has less effect on ISV growth.
If oxidative stress disrupts vascular growth, then H 2 O 2 -treated prdx1 morphants are predicted to be more susceptible to vascular defects. To test this hypothesis, we sought to determine if combined low dose of prdx1 MO injection and low dose of H 2 O 2 treatment had enhanced phenotype. At 30 hpf, in uninjected control embryos, ISV reached the DLAV and the CVP formed loop structures at the tail (Fig. 4G) . Low-dose prdx1 MO (Fig. 4I) or low-dose H 2 O 2 treatment (Fig. 4H) showed mild or no effects on ISV growth and CVP development. However, a combination of prdx1 MO injection and H 2 O 2 treatment resulted in severe vascular defects in ISV growth and CVP formation (Fig. 4J) . Quantification of the percentage of completed ISV and CVP structures showed a synergistic reduction in prdx1 MO injection and H 2 O 2 -treated embryos (n = 10 for wt, prdx1 MO low , 1 mM H 2 O 2 -treated embryos, and H 2 O 2 -treated prdx1 MO low ) at 30 hpf (Fig. 4K,L) . These data suggest oxidative stress disrupts vessel growth. However, H 2 O 2 and prdx1 MO may impair vascular patterning via different regulation mechanisms.
Moreover, when prdx1 morphants were treated during incubation with NAC, a known ROS inhibitor, the vascular defects of ISV and CVP in prdx1 MO were alleviated (Fig. 5B,C) as compared to wild-type control (Fig. 5A) . Quantification of the percentage of completed ISVs shows a~20% completion in prdx1 morphants (n = 26 in wt and n = 35 in prdx1 MO) at 28 hpf. Fifty micromolar and 100 lM of NAC treatment in prdx1 morphants restored the percentage of completed ISV to 44% and 65%, respectively. These data suggest the increased ROS level in prdx1 morphants and oxidative stress both disturb vascular development. Altogether, we show a novel function of prdx1 that play critical roles in vascular growth during zebrafish development.
Overexpression of prdx1 promotes vascular development and restores the ISV defects in prdx1 MO
To test whether excess Prdx1 might promote vascular development, we overexpressed prdx1 mRNA in Tg (flk:GFP) fish. Overexpression of prdx1 showed a faster completion percent of ISV (52 AE 13) compared to uninjected controls (20.5 AE 11) at 24 hpf (Fig. 6A-C) . At 30 hpf, we observed 30% more loops in CVP in prdx1-overexpressed embryos compared to wild-type controls (Fig. 6D-F ) fish, we examined whether overexpressing prdx1 contributes to the increase of ISV cells. We showed overexpression of prdx1 at 24 hpf results in an increased average number of number of cells per ISV (2.3 AE 0.3 cells) as compared to wild-type controls (1.5 AE 0.2 cells) (Fig. 6G-I ). These data suggest that prdx1 is necessary and sufficient to promote ISV growth and CVP formation.
In addition, to further confirm the specificity of our MO experiments, we performed rescue experiments by overexpression of prdx1 in prdx1 i2e3 morphant embryos. Injection of prdx1 mRNA in prdx1 morphants reverses ISV stalling by~40% compared to injection of prdx1 MO alone (Fig. 6J-M) , suggesting specificity of prdx1 MO knockdown.
Regulation of prdx1 is mediated with Notch and BMP signals
We observed that prdx1 is critical for ISV growth with a decrease in the number of ISV endothelial cells and CVP patterning. Notch signaling has been shown to be important for arterial-venous differentiation and ISV tip cells angiogenesis in the trunk of zebrafish [5] . In addition, BMP signaling regulates angiogenic sprouting from the posterior cardinal vein to form CVP, which is a distinct mechanism of angiogenesis from ISV growth [17] . Thus, we investigated the regulatory interaction between prdx1 and Notch and BMP signals. We inactivated Notch and BMP signals through exogenous DAPT and DM treatment, respectively. We observed that prdx1 expression was upregulated when the Notch signal was inhibited (Fig. 7A-C) . In addition, the expression of prdx1 was downregulated in DM-treated embryos (Fig. 7D-F) . These data suggest that prdx1 could regulate ISV growth via the Notch pathways in the trunk and that prdx1 is regulated by BMP signals, potentially to control CVP patterning.
Discussion
Genetic signaling and redox homeostasis are required for proper the growth and patterning of blood vessels. Many antioxidant genes have been shown to be important for angiogenesis; however, most studies have been performed in adult animals under pathological conditions or in cell culture-based research, and very limited information is available regarding antioxidant genes and vascular development during embryogenesis. A recent study showed Grx2-encoding glutaredoxin 2 to be important for vascular development by remodeling sirtuin1 glutathionylation [26] . This study established that embryonic angiogenesis depends on the redox modification of a single-cysteine residue. Interestingly, in 2007, Potente et al. showed that SIRT1 controls endothelial angiogenic functions by deacetylating Foxo1, an essential negative regulator of blood vessel development, during vascular growth [38] . In addition, Prdx2 regulates platelet-derived growth factor (PDGF) and VEGF activity [28, 29] , and both signals are critical for vascular development [39] .
Here, we report a novel function of peroxiredoxin 1 encoded by prdx1 that plays a critical role in vascular growth during zebrafish development. We showed that prdx1 sequence is highly conserved across species and its mRNA is expressed in developing vessels. Loss of prdx1 by MO knockdown impairs the patterning of ISV and CVP, reduces blood flow, impairs PVC formation, and reduces the expression of vascular markers. We confirmed the efficiency of prdx1 MO knockdown and the vascular defects is prdx1-specific. The growth defect of endothelial cells in prdx1 morphants is likely due to a decrease of cell proliferation and migration, but not apoptotic cell death. Loss of Prdx1 may affect vascular development via increasing oxidative stress as we showed the synergistic effects in H 2 O 2 -treated prdx1 morphants, and the antioxidant agent NAC can rescue the vascular defects in prdx1 MO. Overexpression of prdx1 promotes vascular development and restores the ISV defects in prdx1MO, suggesting the role of prdx1 in vascular development is necessary and sufficient. Finally, we showed the regulation of prdx1 is mediated by Notch and BMP signals. Together, this illustrates that prdx1 acts a critical role in vascular development.
One caveat of our study is that we used MO technology to study loss of prdx1 function. There is recent discussion regarding the gene editing mutants versus transient knockdown using MOs. Kok et al. showed poor correlation between MO and mutant phenotypes, and suggested MOs are unreliable tool [40] . However, Rossi et al. showed in some cases, mutants' failure to phenocopy MO knockdown morphants was due to compensation by the mutants. [41] . In addition, there are some concerns about MO technology, such as specificity of MO effects and off-target effects. However, there are clear guidelines regarding the use of MO antisense oligo as the only tool to perform loss-of-function studies in zebrafish [42] [43] [44] . Thus, with appropriate control experiments, MOs can provide useful genetic approaches for the study of early development. Our MO-based study delineates the function of prdx1 in vasculature and would be interesting to see if mutants show the same phenotype. As use of small molecules targeting the same pathway that prdx1 acts in show the same phenotype or rescue the MO phenotype, we conclude that our MO is targeting prdx1.
We showed prdx1 plays a critical role in vascular growth mediated by maintaining redox homeostasis during zebrafish development. We also observed vascular defects consistent with the reduced expression of vascular markers (Fig. 3) and decreased numbers of arterial and venous endothelial cells in the trunk (data not shown). We confirmed the vascular defects were not due to endothelial cell death. Accordingly, we test whether or not the decrease of endothelial cell switches with the blood lineage. With the knockdown of prdx1, we found the loss of prdx1 dramatically decreased the expression of endothelial cell markers fli and flk concomitant with the increased expression of blood markers gata1, globin, and lmo2 by qPCR analysis (Fig. 8A) . These data suggest Prdx1 promotes endothelial cell fate decision and represses blood lineage development (Fig. 8B) . Production of ROS causes hematopoietic ISV at 27 hpf shows a~40% increase in rescued embryos compared to prdx1 morphants. Percentages of completed ISV are~95 AE 5, 22 AE 11, and 62 AE 15 in wild-type, prdx1 MO, and prdx1 mRNA+ prdx1 MO rescued embryos, respectively. *** refer to P < 0.0001 and * refer to P < 0.01 by an unpaired Student's t-test. Data are represented as means AE SD. Scale bars are 100 lm for all figures.
stem cell (HSC) expansion mediated by stabilizing the transcription factor Hif1a for degradation. Harris et al.
showed that the genetic knockdown of prdx1 increases HSCs by analyzing the increase of runx1 and CD41 [45] . This suggests ROS signals are important for blood formation and prdx1 plays a critical role in HSC differentiation or specification. Our data showed the loss of prdx1 results in increased expression of blood markers coincident with the decreased expression of endothelial identities, suggesting prdx1 likely regulates hemangioblast fate decision at earlier developmental stages. Thus, our study not only showed prdx1 played a critical role in vascular growth but also provides an insightful message of a novel HSC regulator during zebrafish development. Oxidative stress generation by H 2 O 2 treatment impaired CVP patterning but not ISV growth (Fig. 4) , which is a different phenotype from what we observed in prdx1 MO. Two possibilities might explain this difference: (a) In vivo, ROS or oxidative stress is quite dynamic and regulated by the whole cellular antioxidant system. It has been shown that almost all antioxidant genes are induced, including sod1, sod2, prdx family, and catalase while undergoing H 2 O 2 treatment [46] . Thus, we seek to determine whether different regulations exist in prdx1 MO, as we showed downregulation of other antioxidant genes sod1, sod2, catalase, and prdx2 can likely be attributed to the more severe vascular defects in prdx1 MO compared to H 2 O 2 -treated embryos (Fig. S7) . Our results confirm the different impacts in vasculature by H 2 O 2 treatment from prdx1 knockdown and suggest the importance of prdx1 function in vascular development. (b) Another possibility might be the differential regulation of redox signaling or targets in prdx1 MO and H 2 O 2 -treated embryos. In this case, we hypothesize H 2 O 2 treatment has a more significant effect on BMP signaling than VEGF signal and results in CVP mis-patterning but not ISV defects. On the other hand, peroxiredoxin degrades not only hydrogen peroxide but also organic peroxides, which might impair ISV formation. Thus, loss of prdx1 can cause defects in both ISV and CVP. Prdx1 and Prdx2 are over 90% homologous and have similar peroxidase activities. However, Prdx1 and Prdx2 show different affinities for substrates and are differentially regulated by stress-related transcription factors in yeast studies [47] . In mammalian studies, prdx2-deficiency has been shown to reduce angiogenesis by regulating PDGFRII and VEGFR2 activities in vascular endothelial cells. However, knockdown of prdx2 did not show obvious vascular defects in zebrafish (Fig. S3) , suggesting the functional difference in different species. In addition, thioredoxins (trxs) are small ROS scavenger proteins with dithiol in their active sites and their detoxification function is catalyzed by peroxiredoxin. Previous studies have suggested that thioredoxin-1 plays a role in the development of cardiovascular diseases [48, 49] . Thus, we also hypothesize thioredoxin homeostasis might affect vascular development. The vascular function of thioredoxin during embryogenesis remains unclear and future work will address this. This study showed the loss of prdx1 results in vascular defects during embryogenesis. We also showed the regulation of prdx1 is mediated by Notch and BMP signals. However, the detailed regulatory mechanism behind this remains unclear. Regulation of PDGF signaling and VEGFR2 activity by peroxiredoxin 2 has been demonstrated, which is important for vascular remodeling in mice [28, 29] . These data provide direct evidence for redox-dependent regulation of receptor tyrosine kinase (RTK) activity and this mechanism likely also occur on Prdx1 during zebrafish vascular development. On the other hand, many studies have shown Prdx1-mediated cancer cell proliferation and/or migration. For example, knockdown of prdx1 inhibits cancer formation by protecting PTEN from oxidative inactivation in response to proliferation signals [50] . Prdx1 stimulates endothelial cell expression of VEGF via TLR4-dependent activation of HIF-1a [24] . Thus, in mammalian studies, Prdx1 and Prdx2 are regulated differently. Prdx1 is selectively phosphorylated by RTKs and functions as a modulator of local H 2 O 2 levels [51] , whereas Prdx2 is more susceptible to hyperoxidation in cells subjected to sustained global oxidative stress. Therefore, we hypothesize that Prdx1 controls vascular development mediated by PTEN/ Akt-VEGF/Notch activity, the signals of which have been shown to be important for ISV growth in zebrafish. On the other hand, Prdx1 likely acts as a downstream regulator of BMP signaling to control CVP patterning. 
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